Management of Palmar Infection
Palmar infections require urgent surgical drainage combined with empiric broad-spectrum antibiotics covering Gram-positive, Gram-negative, and anaerobic bacteria, with antibiotic selection guided by severity of infection and risk factors for resistant organisms.
Immediate Surgical Management
- Early surgical drainage is the cornerstone of treatment for deep palmar space infections, including thenar space, midpalmar space, and hypothenar space infections 1, 2.
- Urgent surgical exploration and debridement should be performed for suspected deep subfascial space infections to prevent progression to necrotizing infection 1, 2.
- Multiple surgical approaches exist depending on the precise location and extent of infection; selection is based on anatomic involvement 2.
Empiric Antibiotic Therapy
For Typical Palmar Infections (Non-Aquatic, Immunocompetent)
- Vancomycin is recommended for initial empirical therapy to cover MRSA, which is increasingly common in hand infections 1.
- Add an agent active against enteric gram-negative bacilli for immunocompromised patients or following penetrating trauma 1.
- For severe infections with systemic signs, vancomycin plus piperacillin-tazobactam or a carbapenem (imipenem/meropenem) provides appropriate broad-spectrum coverage 1.
For Aquatic-Related Injuries or Suspected Atypical Organisms
- If aquatic exposure is suspected (even if not obvious), consider coverage for Aeromonas hydrophila with doxycycline plus ciprofloxacin 1, 3.
- Aeromonas can cause rapidly progressive palmar space infections with gas formation, mimicking clostridial myonecrosis, and requires aminoglycoside coverage 3.
Definitive Antibiotic Therapy
- Once cultures return, narrow antibiotics based on sensitivities 1.
- For MSSA, use cefazolin or antistaphylococcal penicillin (nafcillin or oxacillin) 1.
- Antibiotics should be administered intravenously initially; transition to oral therapy once clinically improved 1.
- Duration: 2-3 weeks of therapy is recommended for deep space infections 1.
Culture and Diagnostic Studies
- Blood cultures and abscess material cultures should be obtained before initiating antibiotics 1.
- Gram stain of purulent material helps guide initial therapy and can identify unexpected organisms like gram-negative bacilli 1, 3.
- For vesicular-appearing lesions, consider HSV PCR to rule out herpetic whitlow, which would not require antibiotics but rather antiviral therapy 4.
Special Populations and Considerations
Diabetic Patients
- Diabetics with hand infections are at significantly increased risk for propagation to bone, tendons, or deep palmar spaces (73% in one series) 5.
- These patients require more aggressive surgical debridement and have higher amputation rates (63%) 5.
- Mixed infections are common (63% of cases), with pure S. aureus accounting for only 12%; empiric broad-spectrum coverage is essential 5.
- Diabetic renal transplant recipients face 100% amputation rates and require particularly aggressive management 5.
Bite Wounds
- For animal or human bite-related palmar infections, use amoxicillin-clavulanate to cover both aerobic and anaerobic bacteria 1.
- Primary wound closure is not recommended except for facial wounds 1.
Penetrating Trauma with Foreign Bodies
- Retained foreign bodies (e.g., seashell fragments) can complicate infections and require thorough surgical exploration and removal 6.
- Consider atypical organisms based on the mechanism of injury 6, 3.
Post-Operative Management
- Aggressive hand therapy is required postoperatively to prevent tendon adhesions, joint contractures, and hand stiffness 2.
- Repeat imaging should be performed in patients with persistent bacteremia to identify undrained foci 1.
- Elevation of the affected extremity is recommended to reduce edema 1.
Common Pitfalls
- Do not mistake herpetic whitlow for a bacterial abscess; vesicular appearance should prompt HSV testing rather than incision and drainage 4.
- Do not underestimate the severity in diabetic patients; early aggressive intervention is critical to prevent amputation 5.
- Do not overlook aquatic organisms even without obvious water exposure; Aeromonas can occur in non-aquatic environments and requires specific antibiotic coverage 3.
- Failure to obtain cultures before antibiotics limits ability to narrow therapy and identify resistant organisms 1.